Roche on Tuesday said it will invest $50 billion in the United States over the next five years, in one of the biggest inward investment moves by companies dealing with President Donald Trump's tariffs policy.

April 22 (UPI) -- Biotechnology giant Roche said it will invest $50 billion into the United States over the next five years. Roche announced Monday that the financial effort will include new research and development sites, as well as both new and expanded manufacturing facilities.

Swiss pharmaceutical giant Roche on Tuesday announced plans to invest $50 billion in the United States over the next five years, following in the footsteps of rival Novartis, with US President Donald Trump's tariff war fuelling uncertainty in the sector.